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During experimental acute pancreatitis, pancreatic acinar
cells die primarily because of necroptosis. Inhibition of
necroptosis either by administration of necrostatin or by
genetic manipulation ameliorates the severity of acute
pancreatitis. Delayed pharmacologic inhibition of nec-
roptosis also reduces disease severity.
BACKGROUND & AIMS: Severe acute pancreatitis is charac-
terized by acinar cell death and inﬂammation. Necroptosis is an
aggressive and proinﬂammatory mode of cell death that can be
prevented by necrostatin-1 administration or receptor-
interacting protein kinase (RIP3) deletion.
METHODS: Mouse pancreatic acinar cells were incubated with
supramaximally stimulating concentrations of caerulein or sub-
micellar concentrations of taurolithocholic acid-3-sulfate (TLCS),
and necroptosis was inhibited by either addition of necrostatin or
by RIP3 deletion. Cell death was quantitated using either lactate
dehydrogenase leakage from acini or propidium iodide staining of
nuclei. Necrosome formation was tracked and quantitated using
cell fractionation or immunoprecipitation. Pancreatitis was
induced in mice by retrograde intraductal infusion of TLCS or by
repetitive supramaximal stimulation with caerulein.
RESULTS: Necroptosis was found to be the most prevalent mode
of acinar cell in vitrodeath and little orno apoptosiswas observed.
Acinar cell death was associated with necrosome formation and
prevented by either necrostatin administration or RIP3 deletion.
Both of these interventions reduced the severity of TLCS- or
caerulein-induced pancreatitis. Delaying necrostatin administra-
tion until after pancreatitis already had been established did not
prevent its ability to reduce the severity of TLCS-induced
pancreatitis.
CONCLUSIONS: Necroptosis is the predominant mode of acinar
cell death in severe experimental mouse pancreatitis. The
severity of pancreatitis can be reduced by administration of
necrostatin, and necrostatin still can reduce the cell injury of
pancreatitis even if it is administered after the disease already
has been established. Inhibition of necroptosis may be an
effective strategy for the treatment of severe clinical pancrea-
titis. (Cell Mol Gastroenterol Hepatol 2016;2:519–535; http://
dx.doi.org/10.1016/j.jcmgh.2016.04.002)
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Apoptosis; Pancreatic Cell Death.cute pancreatitis is a relatively common but poorlyAunderstood inﬂammatory disease involving the
exocrine pancreas. To date, no speciﬁc treatment for acute
pancreatitis has been identiﬁed. The majority of patients
with mild acute pancreatitis recover quickly without speciﬁc
treatment, but roughly 20% of patients with severe
pancreatitis, most of whom have evidence of pancreatic ne-
crosis, experience signiﬁcant morbidity and a mortality rate
that can approach 20%.1,2 The mechanisms responsible for
pancreatic necrosis in acute pancreatitis and the basis for the
high mortality rate in the subgroup of patients with severe
necrotizing pancreatitis are poorly understood, but a better
understanding of these phenomena and identiﬁcation of in-
terventions that could reduce the severity of pancreatitis are
likely to have considerable impact on the treatment and
outcome of this relatively common disease.
Until recently, only 2 forms of cell death had been
recognized: a regulated programmed form of cell death,
referred to as apoptosis, and an unregulated or accidental
form of cell death, loosely referred to as necrosis. Apoptosis
can be mediated by either extrinsic or intrinsic mechanisms,
and most apoptotic cell death involves caspase-dependent
events. It is characterized morphologically by cell
shrinkage and other characteristic cell changes in the
absence of an inﬂammatory response. Terminal deoxy-
nucleotidyl transferase–mediated deoxyuridine triphos-
phate nick-end labeling (TUNEL) staining and measurement
of caspase activity are 2 of many methods of timing and
quantitating the onset and extent of apoptosis. Apoptosis
also is sensitive to inhibition by the pancaspase inhibitor
benzyloxycarbonyl-Val-Ala-Asp (OMe) ﬂuoromethylketone
(Z-VAD-fmk) (reviewed by Galluzzi et al3).
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morphologically by a gain in cell volume, swelling of or-
ganelles, plasma membrane rupture, extravasation of
intracellular contents, and the presence of an acute in-
ﬂammatory response.4 In the past, necrosis was thought
to always be an accidental and uncontrollable mode of
cell death, but recent observations have indicated that
some forms of cell death that morphologically appear to
be necrotic are, in fact, ﬁnely regulated by a set of
intracellular signal transduction pathways.5 The best-
characterized and most widely studied of these regulated
forms of necrosis is necroptosis.3 Necroptosis has
been observed to occur after ligation of death domain
receptors (eg, binding of tumor necrosis factor-a to tumor
necrosis factor–receptor 1) and the process of necroptosis
is known to involve the activation and translocation of the
receptor-interacting protein kinase (RIP)1 and RIP3 ki-
nases and the pseudokinase mixed-lineage kinase like
(MLKL) to a large, amyloid-like, multimolecular scaffold
complex dubbed the necrosome.6–9 By incompletely un-
derstood mechanisms, the assembled necrosome then can
mediate necroptotic cell death. In some cases, necroptosis
is thought to be autophagy-dependent,10 however, by
deﬁnition, it is always dependent on activation of the
kinase RIP13,11 and it can be inhibited by either pharma-
cologic inhibition of RIP1 (eg, by small molecules known
as necrostatins12,13) or by genetic deletion of RIP3.1 Ge-
netic deletion of RIP1 is embryonically lethal, but it now is
known that activation of RIP1 depends on its association
with RIP3 kinase3,11 and, fortunately, genetic deletion of
RIP3 is not embryonically lethal. As a consequence, pre-
vention of RIP1 activation (followed by prevention of
necrosome formation and necroptosis) can be accom-
plished experimentally by genetic deletion of RIP3. Recent
data have shown that MLKL functions as the executioner
molecule in necroptosis, targeting phosphatidylinositol
binding sites and rupturing the plasma membrane.14 The
consequences of preventing necroptotic cell death appear
to be cell- and disease state–speciﬁc. In some cases, it
appears to promote alternative forms of cell death such as
apoptosis, however, in other cases, prevention of nec-
roptosis leads to events that favor cell survival.13
In the current article, we report the results of studies
designed to examine the mode of pancreatic acinar cell
death during the early stages of 2 experimental mouse
models of severe pancreatitis: bile acid–induced and
secretagogue-induced severe pancreatitis. Our studies had
the following 4 primary goals: (1) to identify the most
prevalent mode of cell death during the early stages of these
2 models of severe pancreatitis; (2) to examine the sequence
and timing of some of the events related to acinar cell
necroptotic cell death during the evolution of severe
pancreatitis; (3) to deﬁne the effects on pancreatitis severity
of inhibiting this most prevalent mode of cell death; and (4)
to examine the possibility that inhibiting this mode of cell
death can reduce the severity of pancreatitis even if that
inhibition of cell death occurs after the start of pancreatitis
induction.Materials and Methods
Materials
The amylase substrate (2-chloro-p-nitrophenyl-a-malto-
trioside), the lactate dehydrogenase substrate (lactate), and
the indicator for lactate dehydrogenase assay (nicotinamide
adenine dinucleotide) were purchased from Sekisui
Diagnostics Chemical Ltd (Exton, PA). Two-bis (2-
aminophenoxy)-ethane-N,N,N0,N0-tetraacetic acid (BAPTA),
the caspase-3, -7 substrate Z-DEVD-AMC (benzyloxycarbonyl-
Asp-Glu-Val-Asp-7-amino-4-methylcoumarin), and the pan-
caspase substrate rhodamine 110 bis (l-aspartic acid amide)
(D2R110) were obtained from Life Technologies (Carlsbad,
CA). The pancaspase inhibitor benzyloxycarbonyl-Val-Ala-Asp
(OMe) ﬂuoromethylketone; (Z-VAD-fmk or ZVAD) and poly-
vinyldiﬂuoride membranes were purchased from EMD Milli-
pore (Billerica, MA). Ridaifen B, a tamoxifen analog that is a
known inducer of apoptosis,15 was purchased from Sigma-
Aldrich (St. Louis, MO). The luciferase-based adenosine
triphosphate (ATP) assay was obtained from Perkin Elmer.
Antibodies against RIP3 were purchased from Cell Signaling
(Beverly, MA) while antibodies against total MLKL and phos-
phorylated MLKL were from Abcam (Cambridge, MA). Anti-
bodies against RIP1were fromProSci (Poway, CA). Dulbecco’s
modiﬁed Eagle medium mixed 1:1 with Ham’s F12 salts
(DMEM-F12) and sodium pyruvate were from Life Technolo-
gies. Nitex mesh ﬁlters were purchased from Sefar America
(Kansas City, MO). Necrostatin-1 was obtained from Enzo Life
Sciences (Farmingdale, NY). Caerulein was purchased from
Bachem (Torrance, CA). The TUNEL-staining kit was pur-
chased from Millipore (Waltham, MA). For immunoprecipita-
tion we used the Classic Magnetic IP/Co-IP kit from
ThermoFisher Scientiﬁc (Waltham, MA). The enzyme-linked
immunosorbent assays for monocyte chemoattractant pro-
tein 1 (MCP-1) and interleukin (IL)6 were purchased from
R&D Systems, Minneapolis, MN). Taurolithocholic acid 3-
sulfate disodium salt (TLCS), propidium iodide and all other
chemicals were of analytic grade and purchased from Sigma-
Aldrich (St. Louis, MO).
Experimental Animals
All experiments were performed using non–sex-selected,
wild-type C57Bl/6 mice (20–30 g) purchased from Jackson
Labs (Bar Harbor, ME), or 20–30 g RIP3-/- mice, of either
sex, that had been bred from founder C57Bl/6 knock-out
animals kindly donated by Dr Xiaodong Wang (University
of Texas Southwestern Medical Center).16 These mice were
back-crossed to a C57Bl/6 background for 10 generations.
The animals were housed in temperature-controlled (23C
± 2C) rooms with a 12:12-hour light:dark cycle, fed stan-
dard laboratory chow, and allowed water ad libitum. All
experiments were performed according to protocols
approved by the Animal Care and Use Committee of the
Tufts Medical Center.
Preparation of Pancreatic Acini and Fragments
Pancreatic acini (1–100 cells per cluster) were freshly
prepared for each experiment using collagenase digestion in
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ously described.17 They were suspended in DMEM/F12
containing 3 mmol/L Na-pyruvate and 0.01% (0.1 mg/mL)
bovine serum albumin. The freshly prepared acini were
passed through a 150-mm Nitex ﬁlter before use. For
preparation of pancreatic fragments, freshly harvested
portions of pancreas were minced, in the absence of colla-
genase, to create small (<0.5 mm3) pieces as previously
described.18 In experiments involving BAPTA, Z-VAD-fmk,
or necrostatin, the freshly prepared acini were incubated at
37C for 30 minutes with or without BAPTA (20 mmol/L), Z-
VAD-fmk (25 mmol/L), necrostatin (50 mmol/L), or vehicle
(0.1% dimethyl sulfoxide [DMSO]) before incubation with
TLCS or caerulein.
Measurement of In Vitro Acinar Cell Necrosis
In vitro acinar cell injury/death was quantitated using 2
independent methods: (1) measuring the rate of lactate de-
hydrogenase (LDH) leakage from acini and (2) measuring the
rate of propidium iodide (PI) uptake by acini. LDH activity
was measured by determining the rate of increase in ab-
sorption at 340 nm resulting from the conversion of oxidized
nicotinamide-adenine dinucleotide to reduced nicotinamide
adenine dinucleotidewhen L-lactate is converted to pyruvate.
By using the LDH technique, cell injury/death was quanti-
tated bymeasuring the LDH activity in the acinar supernatant
at the end of the incubation period (1, 2, 4, or 6 hours at 37C)
as a percentage of that noted after cell lysis with 0.5% Triton
X-100 (Sigma-Aldrich, St. Louis, MO). For quantitation of cell
injury/death using PI, the acini were plated in 96-well plates
inmedium containing 1 mg/mL PI. After incubation (1, 2, 4, or
6 hours at 37C), PI ﬂuorescence in the acini was quantitated
with aWallac-Victor ﬂuorescence plate reader (Perkin Elmer,
Waltham, MA) (excitation, 536 nm; emission, 617 nm). The
acini then were lysed by addition of Triton X-100 (ﬁnal con-
centration, 0.5%), and PI ﬂuorescence was re-measured to
determine the value of total PI ﬂuorescence in the sample.
When using the PI technique, cell injury/deathwas expressed
as the percentage of total PI ﬂuorescence that was observed
after detergent lysis.
Measurement of In Vitro Acinar Cell Apoptosis
The extent of acinar cell apoptosis was evaluated by
quantitating TUNEL staining in pancreas fragments and by
quantitating caspase activity in suspended acini. TUNEL
staining was performed according to the kit manufacturer’s
instructions (Millipore, Waltham, MA) after incubation with
test agents for 3 or 6 hours at room temperature. Caspase
activity was measured as described previously.19,20 Brieﬂy,
acini were harvested after predetermined periods of incu-
bation with TLCS, caerulein, or ridaifen B. They were
washed in microfuge tubes with Tris-buffered saline (TBS)
by centrifugation at 300  g for 60 seconds at room tem-
perature and then homogenized and lysed in pH 7.5 buffer
containing 50 mmol/L Tris HCl, 150 mmol/L NaCl, and 0.5
mmol/L EDTA. The samples were centrifuged at 15,000  g
for 15 minutes and the resulting supernatant then was
incubated with 9 volumes of 25 mmol/L HEPES, pH 7.5,10% sucrose, 0.1% 3-[(3-Cholamidopropyl)dimethylammo-
nio]-1-propanesulfonate hydrate, 10 mmol/L dithiothreitol,
and 20 mmol/L of the caspase-3, caspase-7 ﬂuorogenic
substrate Z-DEVD-AMC, or the caspase substrate D2R110.
Fluorescence emission was measured at 440 nm after
excitation at 360 nm (Z-DEVD-AMC), and at 521 nm after
excitation at 498 nm (D2R110).
Calculating the In Vitro Fractional Rate of
Necroptotic Versus Apoptotic Acinar Cell Death
For these studies, we deﬁned necroptotic cell death as the
mode of cell death that could be inhibited by the RIP1 inhibitor
necrostatin-1 and apoptotic cell death as themodeof cell death
that could be inhibited by the pancaspase inhibitor ZVAD. Net
TLCS-induced increases in PI uptake or LDH leakagewereﬁrst
calculated by subtracting the values obtainedwhen acini were
incubated with buffer alone (ie, PI uptake, 14.0% ± 2.0% of
total; LDH leakage, 8.3% ± 2.5% of total) from the values ob-
tained after acini were incubated with TLCS, TLCS þ necros-
tatin, TLCS þ ZVAD, TLCS þ necrostatin þ ZVAD. We believe
that this subtraction is justiﬁed because it reﬂects the fact that
suspensions of acini notoriously are contaminated by injured,
dying, and dead cells that leak LDH andﬂoating free nuclei that
would be expected to bind PI. Those artifacts, created in the
process of preparing suspensions of acini, would be expected
to add to the noise of quantitating changes that really are
indicative of events subsequently induced by test agents such
as caerulein or TLCS, which, after all, was the purpose of our
experiments. The same calculation was used to quantitate net
caerulein-induced increases in PI uptake and LDH leakage.
Once net caerulein- and TLCS-induced cell death had been
calculated accurately, we expected that we would be able to
quantitate more accurately the effects of necrostatin, ZVAD, or
necrostatin þ ZVAD on the net TLCS- and caerulein-induced
cell death.
Fractionation of Acinar Cells to Yield a
Necrosome-Containing Pellet
After varying periods of incubation at 37C with test
agents, the aciniwere harvested by centrifugation (60 s, 300
g) and then washed at 4C with TBS containing a cocktail of
protease inhibitors (Complete; Roche Diagnostics, Indian-
apolis, IN), 1 mmol/L phenylmethylsulfonyl ﬂuoride, and
phosphatase inhibitors (1 mmol/L NaF, 1 mmol/L b-glycer-
ophosphate, and 1 mmol/L sodium orthovanadate). The cells
then were lysed in the same buffer containing 1% NP-40 and
the lysate was centrifuged (20,000  g) for 15 minutes at
4C.7,8,10 The NP-40 soluble supernatant was substituted with
one-quarter volume of 5 Laemmli buffer, and the NP-
insoluble necrosome-containing pellet was dissolved in
Laemmli buffer in volume equal to that of the supernatant and
boiled for 2 minutes to achieve complete denaturation.
Immunoblot Studies of the
Necrosome-Containing Fractions
Proteins in the acinar cell fractions were separated by
sodium dodecyl sulfate–polyacrylamide gel electrophoresis
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Empty sites were blocked with 0.1% bovine serum albumin
in TBS containing 0.05% Tween-20. The membranes then
were incubated overnight at 4C with the primary antibody
(anti-RIP1, anti-RIP3, total-MLKL, or phospho-MLKL) at 0.5
mg/mL in TBS containing 0.05% Tween-20, followed by
incubation with a goat anti-mouse or goat anti-rabbit
horseradish peroxidase antibody (2 mg/mL) for 2 hours at
room temperature. Positive bands were visualized with
FluorChem (ProteinSimple, Inc, San Jose, CA) using the
Promega chemiluminescence kit (Madison, WI).Immunoprecipitation to Obtain a
Necrosome-Containing Immunoprecipitant
Cells were lysed in radioimmunoprecipitation assay
buffer (50 mmol/L Tris, HCl, pH 7.4, 150 mmol/L NaCl,
0.5% sodium deoxycholate, 0.1% sodium dodecyl sulfate,
and 1% N-40) in the presence of protease and phosphatase
inhibitors, and immunoprecipitation was performed ac-
cording to the manufacturer’s instructions (Classic Magnetic
IP/Co-IP kit; ThermoFisher Scientiﬁc, Waltham, MA). Brieﬂy,
the cell lysate was centrifuged at 300g for 60 seconds to
remove debris and the supernatant was incubated with 1
mg/mL anti-RIP1 antibodies overnight at 4C. Twenty-ﬁve
microliters of the protein A/G magnetobeads were added
and the sample was incubated while rotating at 4C for 2
hours. The beads were washed 3 times and bound proteins
were eluted with 0.1 mol/L glycine, HCl pH 2.5. The eluent
was neutralized and subjected to immunoblot analysis with
antibodies against RIP1 and RIP3.ATP Measurement
ATP levels were determined by the luminescence ATP
detection assay system purchased from Perkin Elmer. Brieﬂy,
acini were treated with caerulein or TLCS for a pre-
determined time, and lysed by addition of half volume (50
mL) of lysis buffer. After mixing for 5 minutes, another 50 mL
of substrate buffer containing D-luciferin and luciferase was
added. The generated light was measured using the Wallac-
Victor luminescence plate reader (Perkin Elmer). ATP
depletion was calculated by subtracting the ATP levels found
on acini incubated with certain reagents from the ATP levels
found in control untreated acini. ATP depletion is presented
as a percentage of control untreated acini.Induction of Pancreatitis and
Evaluation of Pancreatitis Severity
Bile acid–induced pancreatitis was elicited by retrograde
pancreatic duct infusion of 50 mL of 10 mmol/L TLCS in
phosphate-buffered saline at a rate of 5 mL/min as described
previously by our group.21 Secretagogue-induced pancrea-
titis was elicited by giving mice hourly intraperitoneal in-
jections of caerulein (50 mg/kg body weight per injection)
for 12 hours. Animals were killed by CO2 asphyxiation 20
hours after the retrograde pancreatic duct infusion or 24
hours after the start of caerulein administration. Thirty
minutes before the induction of pancreatitis, mice to betreated with necrostatin received an intraperitoneal injec-
tion of 100 mL per 20 g mouse of a solution containing 1.20
mg/mL necrostatin in phosphate-buffered saline containing
5% DMSO. The ﬁnal dose of necrostatin delivered was 6
mg/kg. Thirty minutes before the induction of pancreatitis,
mice treated with ZVAD received an intraperitoneal injec-
tion of 200 mL per 20 g mouse of phosphate-buffered saline
containing 1.17 mg/mL ZVAD and 5% DMSO. The ﬁnal dose
of ZVAD was 11.7 mg/kg. Control mice received only the
vehicle. Pancreatitis severity was evaluated at the time of
death by quantitating hyperamylasemia, pancreatic edema
(ie, pancreatic water content), pancreatic inﬂammation (ie,
pancreatic myeloperoxidase activity), and acinar cell injury/
necrosis as previously described.22 Randomly selected re-
gions of the pancreas were used for measurements
involving the gland in the caerulein-induced model because
that model is characterized by changes that are distributed
diffusely within the gland. On the other hand, pancreatic
measurements in the bile acid model were all made using
portions of the pancreatic head because that model is
characterized by changes that primarily, and most repro-
ducibly, are localized to the pancreatic head. For this pur-
pose, the mouse pancreatic head was deﬁned as the portion
of the gland that is located within 5 mm of the lesser
duodenal curvature.
Measurement of Plasma Cytokine Levels
Plasma MCP-1 and IL6 levels during caerulein- and
TLCS-induced pancreatitis were measured by enzyme-
linked immunosorbent assay, according to the manufac-
turer’s instructions (R&D Systems, Minneapolis, MN).
Data Analysis
All results were expressed as mean ± SD values. Graphs
and tables report results obtained from at least 3 indepen-
dent in vitro experiments each performed at least in
duplicate or, for in vivo experiments, in 5 and usually more
independently evaluated animals in each group. The signif-
icance of differences was evaluated using a 2-tailed Student
t test for paired values and 1-way analysis of variance when
multiple groups were being compared. Signiﬁcant differ-
ences are marked by asterisks in all Figures and deﬁned as
those associated with a P value less than .05.
Results
Our studies involved either exposure of acini or frag-
ments to TLCS or caerulein under in vitro conditions or
induction of either the secretagogue or the bile acid model
of in vivo pancreatitis. PI uptake and LDH leakage from
acinar cells were used to quantitate in vitro cell death and
morphometric measurement of cell injury/death in the
pancreas were used to quantitate in vivo cell death.
Time Course of In Vivo and In Vitro
Acinar Cell Death
As shown in Figure 1A, both caerulein and TLCS trigger
accelerated in vitro PI uptake by acinar cells, which is ﬁrst
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Figure 1. Time dependence and mode of acinar cell injury/death after exposure to TLCS or caerulein. (A) Time
dependence of in vitro acinar cell injury/death after exposure to TLCS or caerulein. Acini were incubated with 250 mmol/L TLCS
or 100 nmol/L caerulein for the indicated times and PI uptake was quantitated as described in the Materials and Methods
section. Asterisks indicate a P value less than .05 when compared with untreated acini. (B) Time dependence of in vivo
acinar cell injury/death after retrograde ductal infusion of TLCS. Mice were infused with TLCS to induce pancreatitis as
described in the Materials and Methods section, and killed at the indicated times after completion of the infusion. Acinar cell
injury/death was quantitated morphometrically and expressed as the percentage of acinar tissue. Asterisks indicate a P value
less than .05 when compared with zero-time value. (C–F) In vitro cell death induced by TLCS or caerulein (caer) is inhibited by
necrostatin-1 (nec), but not ZVAD. Acini were incubated for 4 hours in buffer containing 250 mmol/L TLCS or 100 nmol/L
caerulein along with the RIP1 inhibitor necrostatin (50 mmol/L), the pancaspase inhibitor ZVAD (25 mmol/L), or necrostatin plus
ZVAD. After incubation, net TLCS- and caerulein-induced PI uptake and LDH leakage over 4 hours were quantitated as
described in the Materials and Methods section and expressed as a percentage of total PI uptake or LDH leakage measured
after cell lysis with Triton X-100. The PI results show the average ± SD values of 5 experiments performed in quadruplicate and
the LDH results are from 3 experiments performed in duplicate. Asterisks indicate a P value less than .05 when bracketed
columns were compared.
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Table 1.Percentage Reduction in TLCS-Induced Net Acinar Cell Injury/Death
Conditions PI uptake (% total) P value LDH leakage (% total) P value
Necrostatin 69.9 ± 16.5 <.05 55.0 ± 14.6 <.05
ZVAD 3.3 ± 0.8 No reduction -15.0 ± 14.6 No reduction
Necrostatin þ ZVAD 69.4 ± 12.4 <.05 53.2 ± 13.7 <.05
NOTE. Freshly prepared pancreatic acini were incubated with 250 mmol/L TLCS for 4 hours in the presence of buffer alone,
necrostatin, ZVAD, or necrostatin þ ZVAD. PI uptake as well as LDH leakage were measured as described in the text and net
PI uptake and LDH leakage were calculated by subtracting the values obtained with buffer alone. The percentage reduction in
TLCS-induced net PI uptake and LDH leakage brought about by exposure to necrostatin, ZVAD, or necrostatin þ ZVAD
then was calculated. P values reﬂect the differences between the values obtained for PI uptake and LDH leakage triggered by
TLCS alone.
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and is even greater 6 hours after the start of incubation. As
shown in Figure 1B, morphometric evidence of TLCS-
induced in vivo cell injury/death is ﬁrst apparent 2 hours
after TLCS infusion, and further increases to reach a
maximal level 6 hours after TLCS infusion.
In Vitro Studies
Necrotic cell death. As shown in Figure 1C–F, incubation
of acini with either 250 mmol/L TLCS or 100 nmol/L caer-
ulein increases both PI uptake and LDH leakage. After in-
cubation with 250 mmol/L TLCS alone for 4 hours the net
increase in PI uptake was 8.4% ± 2.2% of total, whereas that
for LDH leakage was 5.0% ± 1.4%. Similarly, after incubation
with 100 nmol/L caerulein the net increase in PI uptake was
11.3% ± 2.3% of total, whereas that for LDH leakage was
18.1% ± 3.7%. These increases in net LDH leakage and PI
uptake are reduced by pretreatment of the acinar cells with
the necroptosis (and RIP1) inhibitor necrostatin, but
increased net LDH leakage and PI uptake were not reduced
by the apoptosis (and pancaspase) inhibitor ZVAD. Inclusion
of both necrostatin and ZVAD results in net LDH leakage and
PI uptake, which were the same as those noted when only
necrostatin was added. More than 50% of the net cell death
induced by TLCS or caerulein and quantitated by measuring
either net LDH leakage or PI uptake was prevented by
necrostatin, suggesting that it was the result of necroptosis,
whereas virtually no reduction in either net TLCS- or
caerulein-induced LDH leakage or PI uptake was elicited by
ZVAD (Tables 1 and 2).Table 2.Percentage Reduction in Caerulein-Induced Net Acina
Conditions PI uptake (% total) P
Necrostatin 80.9 ± 3.2
ZVAD 22.4 ± 0.8
Necrostatin þ ZVAD 88.2 ± 15.2
NOTE. Freshly prepared pancreatic acini were incubated with 10
necrostatin, ZVAD, or necrostatin þ ZVAD. PI uptake as well as
PI uptake and LDH leakage were calculated by subtracting the v
caerulein-induced net PI uptake and LDH leakage brought abo
then was calculated. P values reﬂect the differences between th
caeruein alone.Apoptotic cell death. We used 2 separate but comple-
mentary techniques (TUNEL staining and caspase-3 and
caspase-7 activation) to quantitate TLCS- or caerulein-
induced apoptosis in pancreatic fragments. Ridaifen, which
is a tamoxifen analog and a known inducer of apoptosis,16,23
triggers extensive TUNEL staining of acinar cells (Figure 2A
and B) and it increases caspase-3 and caspase-7 activity
(Figure 2C). Both ridaifen-induced TUNEL staining and
ridaifen-induced caspase activity are inhibited by ZVAD. We
used ridaifen as an internal control to determine if
pancreatic acini are capable of undergoing apoptosis,
detected by TUNEL staining and caspase activation, under
the conditions of our experiments. In contrast to ridaifen,
however, neither caerulein nor TLCS trigger either TUNEL
staining or an increase in caspase activity. In other
apoptosis studies (not shown) performed using the caspase
substrate D2R110, increased substrate cleavage initially
presumed to reﬂect caspase activation was observed after
exposure to ridaifen, TLCS, or caerulein, but that increased
substrate cleavage was not inhibitable by the pancaspase
inhibitor ZVAD, suggesting that it was not mediated by
caspases but, more likely, by other, noncaspase acinar cell
enzymes.
Necrosome formation. One of the initial events in the
necroptotic mode of cell necrosis involves formation of a
multimolecular scaffold-like complex known as the
necrosome. For our studies of necrosome formation, 2
techniques were used. For most of our studies, acinar cells
were lysed with detergent and, using centrifugation, 3 frac-
tions were obtained: the total lysate; the high-speedr Cell Injury/Death
value LDH leakage (% total) P value
<.05 63.0 ± 8.9 <.05
<.05 19.0 ± 5.5 >.05
<.05 73.9 ± 19.5 <.05
0 nmol/L caerulein for 4 hours in the presence of buffer alone,
LDH leakage were measured as described in the text and net
alues obtained with buffer alone. The percentage reduction in
ut by exposure to necrostatin, ZVAD, or necrostatin þ ZVAD
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indicate means ± SD values from 3 experiments performed in duplicate. Asterisks indicate a P value less than .05 when
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July 2016 Necroptosis and Experimental Pancreatitis 525supernatant; and the high-speed, detergent-insoluble pellet.
Others have used this technique and shown that necrosomes
are located in this high-speed, detergent-insoluble fraction.7,8
For conﬁrmatory in vitro studies examining necrosome for-
mation, we used a second technique: evaluation of RIP1/
RIP3 co-immunoprecipitation from detergent-lysed acini. As
shown in Figure 3A and B, exposure of acini to either caer-
ulein or TLCS for 2 hours leads to formation of a detergent-
insoluble pellet that contains both RIP1 and RIP3. As shown
in Figure 3C, co-immunoprecipitation of RIP1 and RIP3 can
be ﬁrst detected in the lysate of cells exposed to either
caerulein or TLCS for 2 hours.
As shown in Figure 3D–G, RIP1 and RIP3 are co-
fractionated in the detergent-insoluble pellet of cells
exposed to either caerulein or TLCS, and that co-fractionationis prevented by inclusion of necrostatin along with caerulein
or TLCS in the incubation mixture. In addition to RIP1 and
RIP3, MLKL also can be detected in the detergent-insoluble
pellet obtained from cells incubated with either caerulein
or TLCS (Figure 3H and I) and the total cell lysate contains
phospho-MLKL (p-MLKL) in addition to total MLKL
(Figure 3J). Finally, as shown in Figure 3K and L, co-
fractionation of RIP1 in the detergent-insoluble pellet is
not altered by inclusion of ZVAD along with caerulein or
TLCS in the cell incubation mixture.
Effects of RIP3 genetic deletion on TLCS- and
caerulein-induced cell death and necrosome
formation. Enhanced LDH leakage, indicative of acinar cell
death after exposure to either TLCS or caerulein, was
reduced in cells obtained from RIP3-/- mice (Figure 4A) and
526 Louhimo et al Cellular and Molecular Gastroenterology and Hepatology Vol. 2, No. 4RIP1 was not detected in the detergent-insoluble fraction of
RIP3-/- acinar cells exposed to either caerulein or TLCS
(Figure 4B).
ATP depletion. Reports by other investigators have indi-
cated that exposure of acinar cells to pancreatitis-inducing
agents such as TLCS or caerulein can cause ATP depletion
in acinar cells.24,25 Our studies were designed to conﬁrm
these earlier ﬁndings and to determine if TLCS- or caerulein-
induced ATP depletion leads to or is caused by necrosome
formation and necroptosis. To accomplish this task, acinar
cell ATP levels were monitored in cells incubated with
either a prosecretory concentration of caerulein (10 pmol/
L), a supramaximally stimulating concentration of caeruleinRIP1
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not altered by inclusion of necrostatin in the incubation
mixture (Figure 5C).
Effects of calcium chelation on TLCS-induced ATP
depletion and on acinar cell death induced by either
caerulein or TLCS. Accelerated calcium inﬂux and path-
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July 2016 Necroptosis and Experimental Pancreatitis 527after exposing acinar cells to agents such as TLCS or caer-
ulein, which trigger pancreatitis. Preloading acinar cells
with the calcium chelator BAPTA can reduce or prevent
those pathologic calcium increases or trypsinogen activa-
tion.30 We show that preloading cells with BAPTA also
prevents the following: (1) ATP depletion (Figure 6A),
(2) necrosome formation (Figure 6B and C), and (3) accel-
erated PI uptake (Figure 6D) after exposure of acini to
either caerulein or TLCS.In Vivo Studies
Necrostatin-1 reduces the severity of either bile acid
(TLCS)-induced or secretagogue (caerulein)-induced
pancreatitis. To examine TLCS-induced pancreatitis, mice
were given an intraperitoneal dose of 6 mg/kg necrostatin
with or without 11.7 mg/kg ZVAD 30 minutes before
intraductal infusion of TLCS and then killed 20 hours after
TLCS infusion. As shown in Figure 7A, the morphologic
severity of pancreatitis was reduced in mice pretreated with
necrostatin but not in mice pretreated with ZVAD, and the
combination of necrostatin plus ZVAD resulted in the same
severity observed when only necrostatin was given. The
morphologic severity of TLCS-induced pancreatitis also was
reduced in RIP3-/- mice (Figure 7A). When individual
parameters of pancreatitis severity were quantitated sepa-
rately, necrostatin and genetic deletion of RIP3, but not
ZVAD, reduced the magnitude of pancreatic edema (ie,
increased pancreas water content), neutrophil inﬁltration
(ie, pancreas myeloperoxidase content), and morphometri-
cally quantitated acinar cell injury/necrosis (Figure 7B–D).
Plasma IL6 and MCP-1 levels also were increased 20 hours
after intraductal infusion of TLCS, and that increase was
reduced by administration of necrostatin or genetic deletion
of RIP3. When secretagogue-induced pancreatitis was eli-
cited, very similar results were obtained (Figure 8A–D, F,
and G), however, in this case, pancreatic neutrophilFigure 3. (See previous page). TLCS- and caerulein-induced
formation. (A and B) Effect of TLCS and caerulein on necrosom
in buffer ± 250 mmol/L TLCS or 100 nmol/L caerulein (caer) ± ne
total lysate (T), the high-speed supernatant (S), and the high-spe
in the Materials and Methods section. These 3 fractions were
against RIP1 and RIP3. (C) Co-immunoprecipitation for RIP1 a
antibodies and protein A/G magnetic beads as described in
beads the immunoprecipitants were subjected to immunoblot a
points to IgG heavy chain). (D–G) Effect of necrostatin on necros
necrostatin and then fractionated to yield a high-speed supernat
fractions then were immunoblotted using (D) anti-RIP1 antibod
munoblots shown in panels D and E, respectively. The ratio of s
speed supernatant is shown. Bracketed columns with asterisks d
of caerulein and TLCS on transfer of MLKL to the necrosome. S
D–G. Asterisks indicate a P value less than .05 when compare
Quantitation of blots in panel H is shown. (J) Exposure of acini to
incubated for 2 hours with buffer, 100 nmol/L caerulein, or 2
immunoblotted using anti-total MLKL (left) and anti–phospho-M
caerulein-induced necrosome formation. Samples were prepare
cate a P value less than .05 when compared with samples not ex
(L) reports results of immunoblot quantitation. (F, G, I, and J) C
periments. NS, statistically nonsigniﬁcant differences when brainﬁltration (Figure 8E) was not altered by necrostatin,
ZVAD, or RIP3 deletion.
Delayed administration of necrostatin after ductal
infusion of TLCS. As shown in Figures 7 and 8, in vivo
acinar cell injury/death was reduced by administration of
necrostatin 30 minutes before intraductal infusion of TLCS.
We performed an additional series of studies designed to
determine if the extent of in vivo acinar cell injury/death in
TLCS-induced pancreatitis could also be reduced if necros-
tatin was administered hours after intraductal infusion of
TLCS. As shown in Figure 9A and B, the morphologic
severity and the morphometric extent of acinar cell injury/
necrosis in TLCS-induced pancreatitis was reduced by
administration of necrostatin even if it was given 2 or 4
hours after the completion of TLCS infusion. As shown in
Figure 9C, acinar cell injury/necrosis in TLCS-induced
pancreatitis was ﬁrst observed 2 hours after TLCS infu-
sion. It continued to increase until 6 hours after TLCS
infusion when it reached a plateau level that remained
constant until the time of death 20 hours after TLCS infu-
sion. That continued increase in acinar cell injury/necrosis
was not observed when mice were given necrostatin either
2 or 4 hours after TLCS infusion. The progression of TLCS-
induced acinar cell injury/death was halted at the time of
necrostatin administration and the extent of injury/necrosis
observed at 20 hours remained essentially identical to that
observed at the time of necrostatin administration.Discussion
The factors that determine the mode of acinar cell death
during pancreatitis as well as its extent are poorly under-
stood but it generally is believed that reducing acinar cell
death during an attack of acute pancreatitis would effect its
outcome favorably. Over the years, students of pancreatitis
have identiﬁed a number of interventions that were found
to reduce pancreatitis severity, however, for the most part,in vitro acinar cell death is associated with necrosome
e formation. Freshly prepared acini were incubated for 2 hours
crostatin-1 (nec). After detergent lysis, samples containing the
ed, detergent-insoluble pellet (P) were obtained as described
subjected to immunoblot analysis using antibodies raised
nd RIP3. Samples were immunoprecipitated with anti-RIP1
the Materials and Methods section. After elution from the
nalysis with antibodies against RIP1 (left) and RIP3 (right) (HC
ome formation. Acini were incubated with caerulein or TLCS ±
ant (S) and a high-speed, detergent-insoluble pellet (P). Those
ies or (E) anti-RIP3 antibodies. (F and G) Quantitation of im-
taining in the high-speed necrosome pellet to that in the high-
enote differences with a P value less than .05. (H and I) Effect
amples were prepared and analyzed as described for panels
d with samples not exposed to either TLCS or caerulein. (I)
caerulein or TLCS leads to MLKL phosphorylation. Acini were
50 mmol/L TLCS and lysed with detergent. The lysate was
LKL (right) antibodies. (K and L) Effect of ZVAD on TLCS or
d and analyzed as described for panels D–G. Asterisks indi-
posed to either TLCS or caerulein. (K) Shows immunoblot and
olumns indicate means ± SD values from 3 independent ex-
cketed columns were compared.
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Figure 4. Genetic deletion of RIP3 reduces LDH leakage
and necrosome formation in acinar cells exposed to
either TLCS or caerulein (caer). (A) LDH leakage. Acini from
wild-type and RIP3-/- mice were prepared and incubated with
caerulein (100 nmol/L) or TLCS (250 or 500 mmol/L) for 4
hours. Cell injury was quantitated by measuring LDH leakage
as described in the Materials and Methods section. Columns
show the results of 3 independent experiments performed in
duplicate. Asterisks denote a P value less than .05 when re-
sults from RIP3-/- mice are compared with wild-type animals.
(B) Immunoblot. Acini from wild-type and RIP3-/- mice were
incubated with TLCS or caerulein for 2 hours as described in
the Materials and Methods section. Necrosome formation
was evaluated using anti-RIP1 antibodies as shown in
Figure 3A. The acini were lysed and fractions containing the
total lysate (T), the high-speed supernatant (S), and the high-
speed necrosome pellet (P) were isolated. They were sub-
jected to immunoblot analysis using antibodies to RIP1. Note
the absence of RIP1 staining in the necrosome fraction (P) of
RIP3-/- cells exposed to either caerulein or TLCS compared
with wild-type cells in Figure 3A.
528 Louhimo et al Cellular and Molecular Gastroenterology and Hepatology Vol. 2, No. 4those interventions have been found to be ineffective if
instituted after the onset of the disease. Unfortunately, the
vast majority of patients with severe pancreatitis only
report to the hospital and become identiﬁed many hours or
even days after the onset of pancreatitis and, for those
patients, the identiﬁed potential interventions have not
proven to be beneﬁcial. As a result, no speciﬁc and effective
therapy for acute pancreatitis has been identiﬁed and most
patients remain dependent on nonspeciﬁc, symptomatic
treatments. It generally is believed that the goal of devel-
oping effective treatments for severe pancreatitis will be
met only if therapies that are effective even after the onset
of severe pancreatitis can be identiﬁed.Apoptotic and necroptotic cell death are the 2 most
widely studied modes of regulated cell death and we
considered both of these modes of cell death to be candi-
dates for involvement in pancreatitis-associated cell death.
Apoptotic cell death is usually a relatively benign, nonin-
ﬂammatory form of cell death in which cells and nuclei
become pyknotic, cellular organelles fragment, and organ-
elles as well as cells eventually are phagocytosed by
neighboring cells or invading professional phagocytic cells.
Most examples of apoptosis are caspase-dependent and
inhibited by pancaspase inhibitors such as ZVAD. In contrast
to apoptosis, necroptosis potentially is a much more
aggressive mode of cell death. It is associated with plasma
membrane rupture, extravasation of cytoplasm and intra-
cellular elements, and an intense inﬂammatory response.
Necroptotic cell death is believed to be initiated by activa-
tion of RIP1 kinase and formation of necrosomes. Small-
molecule necrostatins, such as necrostatin-1, and genetic
deletion of RIP3 prevent necroptosis by preventing RIP1
activation and inhibiting necrosome formation.
We performed both in vitro and in vivo experiments in
efforts to achieve our 4 primary goals. The in vitro experi-
ments involved suspending pancreatic acini or fragments in
buffer containing either a supramaximally stimulating con-
centration of caerulein or a pancreatitis-inducing sub-
micellar concentration of TLCS while in vivo experiments
involved either repetitive hourly administration of a
supramaximally stimulating dose of caerulein or retrograde
pancreatic ductal infusion of TLCS.
We found that suspension of acini in TLCS- or caerulein-
containing medium accelerated LDH leakage from the acini
and enhanced PI uptake into the acini. These manifestations
of cell death were ﬁrst detectable 4 hours after acini were
exposed to TLCS or caerulein and they increased further
over the next 2 hours. We also found that intraductal infu-
sion of TLCS, which elicits severe pancreatitis in mice, also
caused extensive acinar cell injury/death that could be
measured by morphometric quantitation of injured or dead
acinar cells. It was ﬁrst detectable 2 hours after the start of
TLCS infusion, increased further over the next 4 hours, and
then remained constant until the time of death 20 hours
after the start of TLCS infusion.
To identify the mode of in vitro and in vivo acinar cell
death, we added either necrostatin-1 or ZVAD to the in vitro
incubation mixture containing either caerulein or TLCS and
we pretreated mice with either necrostatin or ZVAD before
either intraductal infusion of TLCS or dosing with caerulein.
We found that, under in vitro conditions, necrostatin
inhibited more than 50% of the cell death induced by either
caerulein or TLCS while virtually none of that cell death was
reduced by ZVAD, and the combination of necrostatin with
ZVAD yielded results that were the same as those achieved
with necrostatin alone. Similarly, we found that adminis-
tration of necrostatin before the onset of TLCS infusion
reduced acinar cell injury/death under in vivo conditions
but no reduction in acinar cell injury/death was observed in
mice given ZVAD. Together, these observations indicated
that, under either in vitro or in vivo conditions, most (ie,
>50%) of the acinar cell death observed in acini incubated
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Figure 5. Pancreatitis-inducing concentrations of caerulein or TLCS trigger acinar cell ATP depletion that is not pre-
vented by necrostatin (nec). (A) ATP depletion in response to 100 nmol/L caerulein (caer). Acini were suspended in buffer
containing either a secretory concentration or a pancreatitis-inducing concentration of caerulein (ie, 10 pmol/L or 100 nmol/L,
respectively) and ATP levels at the indicated times were quantitated as described in the Materials and Methods section.
Asterisks indicate a P value less than .05 when ATP levels noted in samples exposed to 100 nmol/L caerulein were compared
with control untreated acini. (B) ATP depletion in response to TLCS. Experiments were performed as described in panel A, but
using either 100 mmol/L or 250 mmol/L TLCS. ATP levels at the indicated times were quantitated as described in the Materials
and Methods section. The results are from 5 independent experiments performed in quadruplicate. Asterisks indicate a P value
less than .05 when the ATP level noted in 250 mmol/L TLCS was compared with the ATP level noted in control untreated acini.
(C) Necrostatin does not prevent caerulein or TLCS-induced ATP depletion. Acini were incubated with 100 nmol/L caerulein or
250 mmol/L TLCS ± 50 mmol/L necrostatin for 60 minutes and ATP levels were measured as described in the Materials and
Methods section. Columns show the means ± SD from 5 independent experiments performed in quadruplicate. NS over
bracketed bars indicates statistically nonsigniﬁcant differences in ATP levels.
July 2016 Necroptosis and Experimental Pancreatitis 529with either caerulein or TLCS or in mice given injections of
caerulein or ductal infusions of TLCS was necroptotic cell
death and little or none of that cell death occurred by
apoptosis. Studies directly measuring apoptosis in pancreas
fragments by TUNEL staining or caspase activity supported
that conclusion and they also showed that inhibition of
necroptosis with necrostatin did not trigger a compensatory
increase in apoptosis. Presumably, the TLCS and caerulein-
induced acinar cell death that remained unaccounted for
after administration of necrostatin and ZVAD (ie, 20%–
40%) occurred by other nonapoptotic or non-necroptotic
mechanisms.
The mechanisms of necroptosis have been studied
extensively in other nonpancreatic tissues.7,15,31 As a regu-
lated form of programmed necrosis, it is deﬁned by its
dependence on early activation of RIP1 and by the fact that
it is initiated by formation of necrosomes. We examined the
process of necroptosis in acinar cells undergoing TLCS- or
caerulein-induced in vitro cell death to determine if
necrosome formation under those conditions conforms to
the characteristics known to be typical of necroptosis inother cell types. We used 2 techniques to characterize
necrosome assembly in our studies: the classic technique of
immunoprecipitation in which 2 or more co-localized pro-
teins are co-immunoprecipitated by antibodies directed at
only one of the proteins; and an alternative technique that
involves detergent lysis of cells followed by centrifugal
fractionation and harvesting of a high-speed detergent-sol-
uble supernatant and a high-speed detergent-insoluble
pellet, the latter of which contains the assembling
necrosomes.7–9,28,30 In both techniques, proteins trans-
located to the assembling necrosomes were identiﬁed by
immunoblot. For ease of presentation, these 2 techniques
for studying necrosome assembly will be referred to as
immunoprecipitation and fractionation.
By using either the fractionation technique or the
immunoprecipitation technique, we found that both RIP1
and RIP3 translocate to the necrosome-containing fraction
of acinar cells exposed to either caerulein or TLCS. In other
studies performed using the fractionation technique, we
found that RIP1 and RIP3 translocation can be prevented by
necrostatin-1 but not by ZVAD. We also found that MLKL,
530 Louhimo et al Cellular and Molecular Gastroenterology and Hepatology Vol. 2, No. 4which is phosphorylated in cells exposed to caerulein or
TLCS, also was translocated to the necrosome-containing
fraction by exposure to caerulein or TLCS. Finally, we
found that genetic deletion of RIP3 prevented acinar cell
injury/death and it also prevented translocation of RIP1 to
the necrosome fraction. Thus, each of these observations
yielded the classic ﬁndings of necroptosis-related studies
performed in other cell types and reported by many
groups.6,31–35 Many of those previously reported studies of
necrosome formation used the immunoprecipitation tech-
nique. Our ﬁnding that identical results were observed using
the fractionation technique supports the conclusion that the
fractionation technique is a reliable method of studying
necrosome formation. Our ﬁndings also strengthen our
conclusion that TLCS and caerulein promote necroptotic cellA
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*death in pancreatic acinar cells and that conclusion is
strengthened even further by our observation that, in both
caerulein- and TLCS-induced pancreatitis, acinar cell injury/
death can be prevented by administration of necrostatin-1.
It generally is believed that the earliest acinar cell
changes during the evolution of caerulein- or TLCS-induced
acute pancreatitis involve a sudden but transient and
pathologic increase in cytoplasmic calcium levels and that
aborting that increase by preloading cells with BAPTA can
prevent subsequent downstream phenomena. We found
that to be the case under in vitro conditions, that is, pre-
loading acinar cells with BAPTA prevented caerulein and
TLCS-induced ATP depletion, necrosome formation, and
acinar cell injury/death. On the other hand, prevention of
necroptosis by adding necrostatin to the caerulein or TLCS
suspending medium does not interfere with TLCS- or
caerulein-induced ATP depletion. Taken together, these
observations aid in deﬁning the sequence of events leading
to acinar cell death in experimental caerulein- or TLCS-
induced pancreatitis. They support the conclusion reached
by other investigators19,25,36–39 that caerulein- and TLCS-
induced cell death follows, rather than precedes, depletion
of acinar cell ATP levels and that ATP depletion, necrosome
formation, and acinar cell injury/death all occur down-
stream of a pathologic increase in acinar cell cytoplasmic
calcium levels.30
To pursue our third primary goal of determining if
prevention of necroptosis would reduce the severity of
experimental severe pancreatitis, we elicited caerulein- and
TLCS-induced pancreatitis in wild-type and RIP3 knock-out
mice and administered either necrostatin, ZVAD, or
necrostatin plus ZVAD to the wild-type mice 30 minutes
before the ﬁrst dose of caerulein or 30 minutes before
ductal infusion of TLCS. We found that the morphologic
changes of both caerulein- and TLCS-induced pancreatitis,Figure 6. Effect of intracellular calcium chelation on ATP
depletion, necrosome formation, and on cell injury. (A)
BAPTA prevents caerulein (caer) and TLCS-induced ATP
depletion. Acini were preincubated with or without BAPTA as
described in the Materials and Methods section, and then
exposed to 100 nmol/L caerulein or 250 mmol/L TLCS. ATP
depletion was quantitated over 60 minutes as described in
the Figure 5 legend. Columns show the means ± SD from 5
independent experiments performed in quadruplicate. Aster-
isks over bracketed columns indicate a P value less than .05.
(B and C) BAPTA prevents caerulein and TLCS-induced
necrosome formation. After preloading acini with or without
BAPTA, necrosome formation was evaluated as described in
Figure 3A. (B) Shows immunoblot and (C) reports results of
immunoblot quantitation. Columns show the average ± SD
from 3 independent experiments. (D) BAPTA prevents caer-
ulein and TLCS-induced cell injury/death. Freshly prepared
acini preloaded with or without BAPTA were exposed to
caerulein (100 nmol/L) or TLCS (250 mmol/L) for 4 hours. PI
uptake was quantitated as described in the Materials and
Methods section and in Figure 1. Columns show the
average ± SD from 5 independent experiments performed in
quadruplicate. Asterisks indicate a P value less than .05 when
bracketed columns were compared. Contr, control.
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Figure 7. Inhibition of RIP1 with necrostatin or genetic deletion of RIP3 reduces the severity of TLCS-induced acute
pancreatitis. Acute pancreatitis was induced by retrograde pancreatic duct infusion of TLCS in wild-type (wt) and knockout
(RIP3-/-) mice as described in the Materials and Methods section, whereas control animals were infused only with saline.
Randomly selected mice were pretreated with 6 mg/kg necrostatin (nec), 11.7 mg/kg ZVAD, or both. Mice were killed 20 hours
after infusion. (A) Photomicrographs. Representative H&E-stained pancreas samples are shown. Scale bar: 200 mm. (B–D)
Pancreatitis severity. Quantitation of edema, inﬂammation, and acinar cell injury/death was accomplished as described in the
text. Vertical columns denote mean ± SD values from 5–9 mice in each group. Asterisks indicate statistically signiﬁcant dif-
ference (P < .05) compared with wild-type mice with TLCS-induced pancreatitis that were not given necrostatin or ZVAD. (E
and F) Necrostatin and genetic deletion of RIP3 reduce plasma IL6 and MCP-1 levels in TLCS-induced pancreatitis. Plasma
samples were obtained at the time of death (20 hours after TLCS infusion), and MCP-1 as well as IL6 levels were measured as
described in the Materials and Methods section.
July 2016 Necroptosis and Experimental Pancreatitis 531as well as the individual parameters of pancreatitis severity
(ie, edema, inﬂammation, injury) all were improved mark-
edly by administration of necrostatin or by genetic deletionof RIP3, but no improvement was observed after adminis-
tration of ZVAD. The improvement noted after the addition
of both ZVAD and necrostatin was similar to that noted after
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Figure 8. InhibitionofRIP1
with necrostatin (nec) or
genetic deletion of RIP3
reduces the severity of
caerulein-induced acute
pancreatitis. Caerulein-
induced acute pancreatitis
was elicited in wild-type
(RIP3þ/þ) and RIP3-/- mice
by hourly intraperitoneal
injections of caerulein
(caer) (50 mg/kg/injection)
given for 12 hours.
Randomly selected mice
were pretreated with 6
mg/kg necrostatin, 11.7
mg/kg ZVAD, or both. The
animals were killed 24
hours after the start of
caerulein administration.
(A) Photomicrographs of
H&E-stained samples
of pancreas. Scale bar:
200 mm. (B–E) Pancrea-
titis severity. Pancreatitis
severity was quantitated
as described in Figure 7.
Columns indicate mean ±
SD values from 5 mice in
each group. Asterisks
indicate a P value less than
.05 when compared with
samples from wild-type
mice that were not given
necrostatin or ZVAD.
(F and G) Necrostatin and
genetic deletion of RIP3
reduce serum IL6 and
MCP-1 levels in caerulein-
induced pancreatitis.
Plasma MCP-1 and IL6
levels were measured from
blood obtained at the time
of death. wt, wild-type.
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RIP3 deletion on plasma chemocytokine levels at the time of
death also were evaluated. We found that administration of
necrostatin or genetic deletion of RIP3 markedly reduced
IL6 and MCP-1 plasma levels in both models of severe
pancreatitis. Taken together, these observations, made using
in vivo mouse models of severe pancreatitis, indicate that
the severity of those models can be reduced substantially by
administration of necrostatin-1 or genetic deletion of RIP3,
interventions that reduce the extent of necroptotic acinar
cell death.
Several previously reported studies have examined the
possibility that inhibition of necroptosis might protect
against caerulein-induced pancreatitis.14,40–42 Most studieshave indicated that RIP3 deletion is protective, but 1 report
indicated that necrostatin may increase caerulein-induced
pancreatitis severity.40 This discrepancy with our results
may have to do with the necrostatin dose used. In that
publication, the investigators administered 1.65 mg/kg
necrostatin whereas we used 6 mg/kg. To our knowledge,
there are no studies evaluating the effects of inhibiting
necroptosis on the severity of bile acid–induced experi-
mental pancreatitis. We were surprised to ﬁnd that although
all pancreatitis severity parameters (edema, acinar cell ne-
crosis, systemic cytokine levels) in both models were
reduced by necrostatin administration or RIP3 deletion,
pancreatic neutrophil inﬁltration was not reduced in the
caerulein model of pancreatitis. Although histology indicates
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Figure 9. Delayed administration of necrostatin (nec) halts progression of TLCS-induced acinar cell injury/necrosis.
(A) Representative photomicrographs are shown. Mice were infused with TLCS while necrostatin was administered at the
indicated times before or after TLCS infusion. The mice were killed 20 hours after the start of TLCS infusion. Scale bar: 200 mm.
(B) Time dependence of the necrostatin effect. Mice were infused with TLCS at zero time and given necrostatin at the indicated
times either before or after TLCS infusion. They were killed 20 hours after TLCS infusion and TLCS-induced acinar cell injury/
death was quantitated by morphometry. Dashed line deﬁnes extend of necrosis in control mice infused with TLCS at time
0 and never given necrostatin. (C) Necrostatin halts the progression of TLCS-induced acinar cell injury/death. Mice were
infused with TLCS at zero time and killed 2, 4, or 6 hours later to quantitate TLCS-induced cell death at those times after TLCS
infusion (solid line). Other mice infused with TLCS at zero time were given necrostatin at those times (2, 4, or 6 hours), but not
killed at those times. Instead, they were killed 20 hours after TLCS infusion. Columns indicate mean ± SD values obtained from
5 mice in each group. Asterisks at 20 hours denote a P value less than .05 for those animals when compared with mice never
given necrostatin. Dashed line allows for comparison of cell death immediately before necrostatin administration and cell death
at the time of sacriﬁce.
July 2016 Necroptosis and Experimental Pancreatitis 533that inﬂammatory cells were reduced, this appears not to be
the case for neutrophils. We have no explanation for these
discrepant ﬁndings.
Our fourth and ﬁnal primary goal was to determine if
inhibition of necroptotic cell death after the start of
pancreatitis induction could reduce the extent of necroptotic
cell death during TLCS-induced experimental pancreatitis.
We chose to use the bile acid–induced model of pancreatitis
for these studies because, in our opinion, its patho-
mechanism most closely resembles that of clinical acute
biliary (gallstone) pancreatitis, which is the most common
form of clinical acute pancreatitis. To test whether admin-
istration of necrostatin after the onset of pancreatitis could
reduce acinar cell death in TLCS-induced pancreatitis, we
changed our protocol for necrostatin administration. Rather
than administer necrostatin 30 minutes before TLCS infu-
sion, as we had performed in our earlier studies, we chose
to administer necrostatin at selected times (2, 4, and 6
hours) after TLCS infusion. To evaluate the effects of this
delayed administration of necrostatin, we would need to
ﬁrst determine the extent of acinar cell death present
immediately before necrostatin administration (ie, 2, 4, or 6
hours after TLCS infusion) and then we would need to
compare that value with the extent of acinar cell death thatwas present when necrostatin-treated mice were killed (ie,
20 hours after TLCS infusion).
Our ﬁndings were quite striking. We found that
morphometrically quantitated acinar cell death in mice
infused with TLCS but never given necrostatin was ﬁrst
increased roughly 2 hours after TLCS infusion and that it
progressively became more increased over the ensuing 4
hours. It ﬁnally reached a plateau value 6 hours after TLCS
infusion, and that plateau was maintained until the time of
animal sacriﬁce 20 hours after TLCS infusion. The pattern of
this response is explained most easily by concluding that
TLCS infusion triggers progressive acinar cell injury/death
for 6 hours but, thereafter, no additional acinar cell death
occurs. Next, we administered necrostatin to TLCS-infused
mice 2, 4, and 6 hours after TLCS infusion and quantitated
acinar cell death at the time of sacriﬁce 20 hours after the
TLCS infusion. We found that administration of necrostatin
2 or 4 hours after TLCS infusion had completely halted the
progression of acinar cell death and the extent of acinar cell
death at 20 hours was nearly identical to that observed
immediately before necrostatin administration 2 or 4 hours
after TLCS infusion. These ﬁndings indicate that adminis-
tration of necrostatin completely halts the progression of
acinar cell death in TLCS-induced pancreatitis and that the
534 Louhimo et al Cellular and Molecular Gastroenterology and Hepatology Vol. 2, No. 4ﬁnal extent of cell death is determined by the extent of cell
death that is present at the time of necrostatin administra-
tion. As a result, signiﬁcant decreases in acinar cell death at
20 hours are achievable by administration of necrostatin 2
or 4 hours after TLCS infusion. Administration of necrosta-
tin 6 hours after TLCS infusion fails to improve the extent of
cell death at 20 hours, presumably because that process
already has reached its maximal level at the time of
necrostatin administration.
In summary, the studies reported in this article indicate the
following: (1) necroptosis is themost prevalentmode of TLCS-
and caerulein-induced in vitro cell death; (2) under in vitro
conditions, TLCS- and caerulein-induced acinar cell nec-
roptosis is characterized by necrosome formation and inhib-
itable by necrostatin administration or RIP3 deletion; (3)
under in vitro conditions, TLCS- and caerulein-induced acinar
cell necroptosis is dependent on a preceding pathologic in-
crease in cytoplasmic calcium levels and it occurs after acinar
cell ATP depletion; (4) the severity of both TLCS- and
caerulein-induced pancreatitis is reduced by prior inhibition
of necroptosis brought about by either necrostatin adminis-
tration or RIP3 deletion; and (5) necrostatin can reduce acinar
cell injury/death during TLCS-induced pancreatitis even if
that necrostatin is administered after infusion of TLCS already
has triggered the onset of experimental pancreatitis.
These observations, which come from mouse models of
pancreatitis, do not guarantee that the same observations
would be obtained in human pancreatitis or even in other
rodent models. However, they suggest that inhibition of
necroptosis might protect against clinical severe pancrea-
titis even if necroptosis inhibition is achieved after the onset
of pancreatitis. In our experiments, necrostatin-1 was used
to inhibit necroptosis but, in the case of clinical pancreatitis,
other methods of inhibiting necroptosis, with differing
pharmacodynamics and toxicities, might prove even more
effective. The time course for clinical pancreatitis will need
to be characterized carefully. Although we have shown that
TLCS-induced pancreatitis in mice evolves over a 6-hour
period and that the window for protection is open for
roughly 4 hours, different times might be critical in clinical
pancreatitis. Regardless of these considerations, however,
our observations indicate that therapies designed to inter-
fere with necroptosis might be an effective strategy for the
treatment of severe clinical pancreatitis, which already has
been established at the time of its diagnosis.
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